Selected research
Market Structure
Global Morning-after Pill Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Morning-after Pill market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Morning-after Pill is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Morning-after Pill is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Morning-after Pill is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Morning-after Pill is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Morning-after Pill include Zizhu Pharma, Zhejiang Xianju Pharma, Syzygy Healthcare, Regenex, Piramal, Mankind Pharma, Lupin, HRA Pharma and HLL Life Care, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Morning-after Pill market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Morning-after Pill and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Morning-after Pill sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Morning-after Pill market size, projected growth trends, production technologies, key applications, and end-use industries.
Morning-after Pill Segment by Company
Zizhu Pharma
Zhejiang Xianju Pharma
Syzygy Healthcare
Regenex
Piramal
Mankind Pharma
Lupin
HRA Pharma
HLL Life Care
Gedeon Richter
Foundation Consumer Healthcare
Morning-after Pill Segment by Type
Levonorgestrel
Ulipristal Acetate
Morning-after Pill Segment by Application
Online
Offline
Morning-after Pill Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Morning-after Pill market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Morning-after Pill and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Morning-after Pill.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Morning-after Pill market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Morning-after Pill manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Morning-after Pill in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Morning-after Pill in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Levonorgestrel
- Ulipristal Acetate
Applications
- Online
- Offline
Companies covered
- Zizhu Pharma
- Zhejiang Xianju Pharma
- Syzygy Healthcare
- Regenex
- Piramal
- Mankind Pharma
- Lupin
- HRA Pharma
- HLL Life Care
- Gedeon Richter
- Foundation Consumer Healthcare
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Morning-after Pill Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Morning-after Pill Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Morning-after Pill Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Morning-after Pill Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Morning-after Pill Market Dynamics
- 2.1 Morning-after Pill Industry Trends
- 2.2 Morning-after Pill Industry Drivers
- 2.3 Morning-after Pill Industry Opportunities and Challenges
- 2.4 Morning-after Pill Industry Restraints
3 Morning-after Pill Market by Manufacturers
- 3.1 Global Morning-after Pill Revenue by Manufacturers (2021-2026)
- 3.2 Global Morning-after Pill Sales by Manufacturers (2021-2026)
- 3.3 Global Morning-after Pill Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Morning-after Pill Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Morning-after Pill Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Morning-after Pill Manufacturers, Product Type & Application
- 3.7 Global Morning-after Pill Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Morning-after Pill Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Morning-after Pill Players Market Share by Revenue in 2025
- 3.8.3 2025 Morning-after Pill Tier 1, Tier 2, and Tier 3
4 Morning-after Pill Market by Type
- 4.1 Morning-after Pill Type Introduction
- 4.1.1 Levonorgestrel
- 4.1.2 Ulipristal Acetate
- 4.2 Global Morning-after Pill Sales by Type
- 4.2.1 Global Morning-after Pill Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Morning-after Pill Sales by Type (2021-2032)
- 4.2.3 Global Morning-after Pill Sales Market Share by Type (2021-2032)
- 4.3 Global Morning-after Pill Revenue by Type
- 4.3.1 Global Morning-after Pill Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Morning-after Pill Revenue by Type (2021-2032)
- 4.3.3 Global Morning-after Pill Revenue Market Share by Type (2021-2032)
5 Morning-after Pill Market by Application
- 5.1 Morning-after Pill Application Introduction
- 5.1.1 Online
- 5.1.2 Offline
- 5.2 Global Morning-after Pill Sales by Application
- 5.2.1 Global Morning-after Pill Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Morning-after Pill Sales by Application (2021-2032)
- 5.2.3 Global Morning-after Pill Sales Market Share by Application (2021-2032)
- 5.3 Global Morning-after Pill Revenue by Application
- 5.3.1 Global Morning-after Pill Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Morning-after Pill Revenue by Application (2021-2032)
- 5.3.3 Global Morning-after Pill Revenue Market Share by Application (2021-2032)
6 Global Morning-after Pill Sales by Region
- 6.1 Global Morning-after Pill Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Morning-after Pill Sales by Region (2021-2032)
- 6.2.1 Global Morning-after Pill Sales by Region (2021-2026)
- 6.2.2 Global Morning-after Pill Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Morning-after Pill Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Morning-after Pill Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Morning-after Pill Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Morning-after Pill Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Morning-after Pill Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Morning-after Pill Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Morning-after Pill Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Morning-after Pill Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Morning-after Pill Revenue by Region
- 7.1 Global Morning-after Pill Revenue by Region
- 7.1.1 Global Morning-after Pill Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Morning-after Pill Revenue by Region (2021-2026)
- 7.1.3 Global Morning-after Pill Revenue by Region (2027-2032)
- 7.1.4 Global Morning-after Pill Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Morning-after Pill Revenue (2021-2032)
- 7.2.2 North America Morning-after Pill Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Morning-after Pill Revenue (2021-2032)
- 7.3.2 Europe Morning-after Pill Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Morning-after Pill Revenue (2021-2032)
- 7.4.2 Asia-Pacific Morning-after Pill Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Morning-after Pill Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Morning-after Pill Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Zizhu Pharma
- 8.1.1 Zizhu Pharma Company Information
- 8.1.2 Zizhu Pharma Business Overview
- 8.1.3 Zizhu Pharma Morning-after Pill Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Zizhu Pharma Morning-after Pill Product Portfolio
- 8.1.5 Zizhu Pharma Recent Developments
- 8.2 Zhejiang Xianju Pharma
- 8.2.1 Zhejiang Xianju Pharma Company Information
- 8.2.2 Zhejiang Xianju Pharma Business Overview
- 8.2.3 Zhejiang Xianju Pharma Morning-after Pill Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Zhejiang Xianju Pharma Morning-after Pill Product Portfolio
- 8.2.5 Zhejiang Xianju Pharma Recent Developments
- 8.3 Syzygy Healthcare
- 8.3.1 Syzygy Healthcare Company Information
- 8.3.2 Syzygy Healthcare Business Overview
- 8.3.3 Syzygy Healthcare Morning-after Pill Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Syzygy Healthcare Morning-after Pill Product Portfolio
- 8.3.5 Syzygy Healthcare Recent Developments
- 8.4 Regenex
- 8.4.1 Regenex Company Information
- 8.4.2 Regenex Business Overview
- 8.4.3 Regenex Morning-after Pill Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Regenex Morning-after Pill Product Portfolio
- 8.4.5 Regenex Recent Developments
- 8.5 Piramal
- 8.5.1 Piramal Company Information
- 8.5.2 Piramal Business Overview
- 8.5.3 Piramal Morning-after Pill Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Piramal Morning-after Pill Product Portfolio
- 8.5.5 Piramal Recent Developments
- 8.6 Mankind Pharma
- 8.6.1 Mankind Pharma Company Information
- 8.6.2 Mankind Pharma Business Overview
- 8.6.3 Mankind Pharma Morning-after Pill Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Mankind Pharma Morning-after Pill Product Portfolio
- 8.6.5 Mankind Pharma Recent Developments
- 8.7 Lupin
- 8.7.1 Lupin Company Information
- 8.7.2 Lupin Business Overview
- 8.7.3 Lupin Morning-after Pill Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Lupin Morning-after Pill Product Portfolio
- 8.7.5 Lupin Recent Developments
- 8.8 HRA Pharma
- 8.8.1 HRA Pharma Company Information
- 8.8.2 HRA Pharma Business Overview
- 8.8.3 HRA Pharma Morning-after Pill Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 HRA Pharma Morning-after Pill Product Portfolio
- 8.8.5 HRA Pharma Recent Developments
- 8.9 HLL Life Care
- 8.9.1 HLL Life Care Company Information
- 8.9.2 HLL Life Care Business Overview
- 8.9.3 HLL Life Care Morning-after Pill Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 HLL Life Care Morning-after Pill Product Portfolio
- 8.9.5 HLL Life Care Recent Developments
- 8.10 Gedeon Richter
- 8.10.1 Gedeon Richter Company Information
- 8.10.2 Gedeon Richter Business Overview
- 8.10.3 Gedeon Richter Morning-after Pill Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.10.4 Gedeon Richter Morning-after Pill Product Portfolio
- 8.10.5 Gedeon Richter Recent Developments
- 8.11 Foundation Consumer Healthcare
- 8.11.1 Foundation Consumer Healthcare Company Information
- 8.11.2 Foundation Consumer Healthcare Business Overview
- 8.11.3 Foundation Consumer Healthcare Morning-after Pill Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.11.4 Foundation Consumer Healthcare Morning-after Pill Product Portfolio
- 8.11.5 Foundation Consumer Healthcare Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Morning-after Pill Value Chain Analysis
- 9.1.1 Morning-after Pill Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Morning-after Pill Production Mode & Process
- 9.2 Morning-after Pill Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Morning-after Pill Distributors
- 9.2.3 Morning-after Pill Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst